» Articles » PMID: 11836499

BRCA1 Regulates the G2/M Checkpoint by Activating Chk1 Kinase Upon DNA Damage

Overview
Journal Nat Genet
Specialty Genetics
Date 2002 Feb 12
PMID 11836499
Citations 165
Authors
Affiliations
Soon will be listed here.
Abstract

The breast cancer tumor-suppressor gene, BRCA1, encodes a protein with a BRCT domain-a motif that is found in many proteins that are implicated in DNA damage response and in genome stability. Phosphorylation of BRCA1 by the DNA damage-response proteins ATM, ATR and hCds1/Chk2 changes in response to DNA damage and at replication-block checkpoints. Although cells that lack BRCA1 have an abnormal response to DNA damage, the exact role of BRCA1 in this process has remained unclear. Here we show that BRCA1 is essential for activating the Chk1 kinase that regulates DNA damage-induced G2/M arrest. Thus, BRCA1 controls the expression, phosphorylation and cellular localization of Cdc25C and Cdc2/cyclin B kinase-proteins that are crucial for the G2/M transition. We show that BRCA1 regulates the expression of both Wee1 kinase, an inhibitor of Cdc2/cyclin B kinase, and the 14-3-3 family of proteins that sequesters phosphorylated Cdc25C and Cdc2/cyclin B kinase in the cytoplasm. We conclude that BRCA1 regulates key effectors that control the G2/M checkpoint and is therefore involved in regulating the onset of mitosis.

Citing Articles

Thirty Years of BRCA1: Mechanistic Insights and Their Impact on Mutation Carriers.

Moser S, Jonkers J Cancer Discov. 2025; 15(3):461-480.

PMID: 40025950 PMC: 11893084. DOI: 10.1158/2159-8290.CD-24-1326.


BRCA1 and BRCA2: from cancer susceptibility to synthetic lethality.

Khalizieva A, Moser S, Bouwman P, Jonkers J Genes Dev. 2024; 39(1-2):86-108.

PMID: 39510841 PMC: 11789497. DOI: 10.1101/gad.352083.124.


Multi-Omic Graph Diagnosis (MOGDx): a data integration tool to perform classification tasks for heterogeneous diseases.

Ryan B, Marioni R, Simpson T Bioinformatics. 2024; 40(9).

PMID: 39177104 PMC: 11374023. DOI: 10.1093/bioinformatics/btae523.


A high-throughput approach to identify BRCA1-downregulating compounds to enhance PARP inhibitor sensitivity.

Sellars E, Savguira M, Wu J, Cancelliere S, Jen M, Krishnan R iScience. 2024; 27(7):110180.

PMID: 38993666 PMC: 11238136. DOI: 10.1016/j.isci.2024.110180.


ReCorDE: a framework for identifying drug classes targeting shared vulnerabilities with applications to synergistic drug discovery.

John A, Ghose E, Gao H, Luck M, Jeong D, Kalari K Front Oncol. 2024; 14:1343091.

PMID: 38884087 PMC: 11176476. DOI: 10.3389/fonc.2024.1343091.